TickerFactsScreenerDevelopers

Revolution Medicines, Inc. (RVMD) — Operating Income

Annual figures by fiscal year, from SEC filings.

2018: -$40.33M2019: -$54.12M2020: -$110.70M2021: -$188.01M2022: -$258.28M2023: -$487.19M2024: -$689.52M2025: -$1.18B-$1.18B
2018Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$1.18B-71.5%
2024-$689.52M-41.5%
2023-$487.19M-88.6%
2022-$258.28M-37.4%
2021-$188.01M-69.8%
2020-$110.70M-104.5%
2019-$54.12M-34.2%
2018-$40.33M—